Minimal deviation adenocarcinoma of the uterine cervix has abnormal expression of sex steroid receptors, CA125, and gastric mucin

International Journal of Gynecological Pathology

Volumn 16, Issue 2, 1997, Pages 111-116

  Toki, Toshihiko ^a   Shiozawa, Tanri ^a   Hosaka, Noriko ^a   Ishii, Keiko ^a   Nikaido, Toshio ^a   Fujii, Shingo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenoma malignum; CA125; Gastric mucin; Minimal deviation adenocarcinoma; Sex steroid receptors; Uterine cervix

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR; STOMACH MUCIN;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA;

EID: 0030993158     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199704000-00005     Document Type: Article

References (23)

1. Silverberg SG, Hurt WG. Minimal deviation adenocarcinoma ("adenoma malignum") of the cervix: a reappraisal. Am J Obstet Gynecol 1975;121:971-5.
2. McKelvey JL, Goodlin RR. Adenoma malignum of the cervix. A cancer of deceptively innocent histologic pattern. Cancer 1963;16:549-57.
3. Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989;13:717-29.
4. Kaku T, Enjoji M. Extremely well-differentiated adenocarcinoma ("adenoma malignum") of the cervix. Int J Gynecol Pathol 1983;2:28-41.
5. Kaminski PF, Norris HJ. Minimal deviation carcinoma (adenoma malignum) of the cervix. Int J Gynecol Pathol 1983;2:141-52.
6. Michael H, Grawe L, Kraus FT. Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembrvonic antigen, and differentiation from confusing benign lesions. Int J Gynecol Pathol 1984;3:261-76.
7. Steeper TA, Wick MR. Minimal deviation adenocarcinoma of the uterine cervix ("adenoma malignum"). An immunohistochemical comparison with microglandular endocervical hyperplasia and conventional endocervical adenocarcinoma. Cancer 1986;58:1131-8.
8. Bulmer JN, Griffin NR, Bates C, Kingston RE, Wells M. Minimal deviation adenocarcinoma (adenoma malignum) of the endocervix: a histochemical and immunohistochemical study of two cases. Gynecol Oncol 1990;36:139-46.
9. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 1994:279-326.
10. Noyes RW, Hertig At, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
11. Katsuyama T, Ota H, Ishii K, et al. Histochemical characterization of gastric mucin-secreting cells and the surface mucous gel layer. In: Gastrointestinal function, regulation and disturbances. Vol. 9. Tokyo: Excerpta Medica, 1991:145-65.
12. Ota H, Katsuyama T, Ishii K, Nakayama J, Shiozawa T, Tsukahara Y. A dual staining method for identifying mucins of different gastric epithelial mucous cells. Histochem J 1991;23:22-8.
13. Young RH, Scully RE. Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix. A clinicopathological analysis of 16 cases, Int J Gynecol Pathol 1988;7:99-111.
14. Ota H, Katsuyama T, Akamatsu T, et al. Application of mucin histochemistry for pathological diagnosis: expression of gastric phenotypes in metaplastic and neoplastic lesions and its relation to the organoid differentiation. Acta Histochem Cytochem 1995;28:43-53.
15. Jaworski RC, Pacey NF, Greenberg ML, Osborn RA. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Adenocarcinoma in situ. Cancer 1988;61:1171-81.
16. Savargaonkar PR, Hale RJ, Pope R, Fox H, Buckley CH. Enteric differentiation in cervical adenocarcinomas and its prognostic significance. Histopathology 1993;23:275-7.
17. Kudo R, Sagae S, Kusanagi T, Mizuuchi H, Hayakawa O, Hashimoto M. Minimal-deviation adenocarcinoma (adenoma malignum) of the uterine cervix; four case reports. Eur J Obstet Gynecol Reprod Biol 1990;34:179-88.
18. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988;67:334-40.
19. Nonogaki H, Fujii S, Konishi I, et al. Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix. Cancer 1990;66:2620-7.
20. Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 1983;2:275-85.
21. Nanbu Y, Fujii S, Konishi I, Nonogaki H, Mori T. CA125 in the epithelium closely related to the embryonic ectoderm: the periderm and amnion. Am J Obstet Gynecol 1989;161:462-7.
22. Tsutsumi Y, Nagura H, Watanabe K. Immunohistochemical observations of carcinoembryonic antigen (CEA) and CEA-related substances in normal and neoplastic pancreas. Pitfalls and caveats in CEA immunohistochemistry. Am J Clin Pathol 1984;81:535-43.
23. Nap M, Hammarstrom M-L, Bormer O, et al. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res 1992;52:2329-39.